Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Obesity drugmaker Rivus is working with banks to complete a US public listing that could happen before the end of the year.
Oil giants Chevron and BP made moves to refine their business, drilling down on core segments that crude demand assures will be worth it.
Amazon’s patent to help doctors take better notes highlights the company’s massive bet on the healthcare space.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Fossil fuel producers and OPEC have rained on the IEA’s parade, offering wildly different projections for future energy demand.
The Food and Drug Administration declared an end to the scarcity of Eli Lilly’s highly in-demand weight-loss and diabetes drugs on Thursday.
Starbucks is buying two farms in Central America to conduct research on the crop at the heart of its business: coffee.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
Toyota is investing $500 million into Joby Aviation, a California-based startup that wants to make flying taxis.
PepsiCo announced on Tuesday that it has agreed to buy Siete Foods for $1.2 billion, another food M&A deal this year.
Boeing is considering an emergency move: selling $10 billion in new stock to score some quick cash amid a union strike.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.